Skip to main content
FinnGen logo
FinnGen
  • EN
  • FI
  • SV
  • Members

Main navigation

  • Research project
    • About us
    • Goals
    • Benefits
    • Partners
    • Code of conduct
    • Funding
    • Governance
    • Research Highlights
    • Working groups
  • Citizens
    • For the sample donor
    • Recall study
    • Role of biobanks
    • Participation
    • Questions and answers
    • Data protection
  • Researchers
    • FinnGen project
    • Access results
    • COVID-19
    • Publications
    • Clinical endpoints
    • Genotyping
    • Partner researchers
    • Timeline
  • Professionals
    • Clinical expert groups
    • For healthcare professionals
    • Industry partners
  • Media
    • Study in a nutshell
    • Why in Finland?
    • Goals and benefits
    • Mediabank
    • Contact information
  • News
  • Members

Main navigation

  • Research project
    • About us
    • Goals
    • Benefits
    • Partners
    • Code of conduct
    • Funding
    • Governance
    • Research Highlights
    • Working groups
  • Citizens
    • For the sample donor
    • Recall study
    • Role of biobanks
    • Participation
    • Questions and answers
    • Data protection
  • Researchers
    • FinnGen project
    • Access results
    • COVID-19
    • Publications
    • Clinical endpoints
    • Genotyping
    • Partner researchers
    • Timeline
  • Professionals
    • Clinical expert groups
    • For healthcare professionals
    • Industry partners
  • Media
    • Study in a nutshell
    • Why in Finland?
    • Goals and benefits
    • Mediabank
    • Contact information
  • News
  • Members
  • EN
  • FI
  • SV

Members area

Access to Members area is restricted to FinnGen Consortium members only. Please contact Human genomics service desk <humgen-servicedesk(at)helsinki.fi> to find out how to obtain an user account.

Login

Please contact Human genomics service desk <humgen-servicedesk(at)helsinki.fi> in case you have forgotten the password

FinnGen in brief

FinnGen is a large public-private partnership aiming to collect and analyse genome and health data from 500,000 Finnish biobank participants. FinnGen aims on one hand to provide novel medically and therapeutically relevant insights but also construct a world-class resource that can be applied for future studies.

FinnGen is one of the very first personalized medicine projects at this scale and the public-private collaborative nature of the project is exceptional compared to many ongoing studies. FinnGen brings together Finnish universities, hospitals and hospital districts, THL, Blood Service, biobanks, FINBB and international pharmaceutical companies and hundreds of thousands of Finns. Because collaboration is the key to achieving breakthroughs in disease prevention, diagnosis, and treatment, we welcome everyone on this journey into our shared heritage.
 

FinnGen logo
FinnGen

Contact us

Contact person
finngen-info@helsinki.fi

Lead organisations

University of Helsinki is the organization responsible for the study. The nationwide network of Finnish biobanks is participating to the study and thus the study covers whole Finland. Helsinki Biobank (the Hospital District of Helsinki and Uusimaa) coordinates the sample collection.

About the website

Accessibility statement